Sean M. Hickey, MD

EMRA Critical Care Committee Vice Chair, 2019-2020

Residency: Mount Sinai School of Medicine
Medical school: Albert Einstein College of Medicine

This review article was trying to take another look at the impact of epinephrine, especially its impact on meaningful neurologic survival, to see if the debates launched by the PARAMEDIC-2 trial were
Can vitamin C benefit patients with sepsis-related ARDS? Take a look at the evidence from the CITRIS-ALI study before you take a stance in this ongoing debate.
Sometimes a clinical trial shows no statistical differences yet can help to illuminate best practices. Count the ESETT Trial as one of them.
Moderate therapeutic hypothermia could be another tool in treating cardiac arrest patients. But how much should a patient be cooled? The HYPERION Trial doesn't resolve that debate.
The SEP-1 core measure instituted by CMS has been hotly debated. A new review of literature shows a lack of high-quality evidence to back up the specificity required in the sepsis bundle.
Fluid resuscitation guidelines for severe sepsis and septic shock presently address only the initial phase of resuscitation. The RIFTS trial examines the efficacy of a restrictive IV fluid resuscitati
Does early neuromuscular blockade accompanied by heavy sedation in ARDS cases improve all-cause in-hospital mortality rates? The ROSE trial investigates.
When trying to resuscitate patients with septic shock, which offers better guidance for intervention: measuring capillary refill or trending lactate levels? The Andromeda SHOCK trial studied patients
CHAT NOW
CHAT OFFLINE